Breaking Down Barriers in Diabetes Care During Diabetes Awareness Month
November is Diabetes Awareness Month, a dedicated time to spotlight a condition that affects over 400 million people worldwide. This month serves as...
market access
Exploring Alternative Payment Models in Healthcare
For years, the standard method of payment to physicians has been “fee-for-service” (FFS). This method was introduced in the 1930s and refers to...
Patient-Centric Approaches: A New Era in Healthcare
The Power of Putting Patients First The landscape of healthcare has undergone a significant transformation, with a renewed focus on patient-centered...
Mind Medicine: The Resurgence of Psychedelic Drugs in Mental Health Care
For hundreds of years, psychedelic drugs have been praised for their medicinal benefits and mind-altering effects. Known also as hallucinogenic,...
Understanding the Alzheimer's Research and Treatment Landscape: From Challenges to Hope
In the book, “Outlive,” Peter Attia refers to neurodegenerative diseases, such as Alzheimer’s and dementia, as one of the “Four Horsemen” of chronic...
Telehealth’s Evolution Beyond Pandemic Response: A Comprehensive Outlook
The COVID-19 pandemic acted as a catalyst for the widespread adoption of telehealth. Initially driven by necessity, virtual care rapidly became an...
Charting the Course: The Rise of Digital Therapeutics in Healthcare
Technological innovation has had an immense impact on healthcare delivery. Novel medical devices and cutting-edge pharmaceuticals continue to...
Mark Cuban’s Cost Plus Drugs: A Game-Changer in Health Accessibility
The escalating cost of prescription drugs has become a pressing concern for patients, healthcare providers, and policymakers alike. In this landscape...
Securing the Future: Navigating Challenges and Opportunities in Medicare
Medicare Advantage has been facing criticism for its administrative and financial delays, and an increasing number of hospitals are scrapping their...
Diversifying Clinical Trials: Navigating the FDA's Roadmap for Inclusive Research
In April 2022, the FDA released draft guidance with recommendations for drug developers and clinical trial researchers. The guidance highlights gaps...